dextroamphetamine has been researched along with finasteride in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bini, V; Bortolato, M; Corona, M; Devoto, P; Flore, G; Frau, R; Marrosu, F; Pillolla, G; Saba, P | 1 |
| Check, JH; Cohen, R | 1 |
1 review(s) available for dextroamphetamine and finasteride
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for dextroamphetamine and finasteride
| Article | Year |
|---|---|
Inhibition of 5α-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation.
Topics: 5-alpha Reductase Inhibitors; Animals; Apomorphine; Cholestenone 5 alpha-Reductase; Dextroamphetamine; Dopamine Agents; Finasteride; Male; Nucleus Accumbens; Orchiectomy; Rats; Rats, Sprague-Dawley; Reflex, Startle; Sensory Gating | 2012 |
Dihydrotestosterone may contribute to the development of migraine headaches.
Topics: 5-alpha Reductase Inhibitors; Contraceptives, Oral; Dextroamphetamine; Dihydrotestosterone; Female; Finasteride; Humans; Migraine Disorders; Polycystic Ovary Syndrome; Spironolactone; Young Adult | 2013 |